ESC Congress 2018: what is the future for PCSK9 inhibitors?
Many patients with high levels of low-density lipoprotein cholesterol (LDL-C) or “bad cholesterol” receive suboptimal...
Read More...
Focus:
-
![abortion in England]()
Abortion in England: legalising home medical abortion pills
The UK Government has decided to legalise home-use of early medical abortion pills in England....
Read More...
-
![]()
Real-time FDA review expedites approval, but is the pilot programme too limited?
On August 20, the FDA granted Merck’s Keytruda (pembrolizumab) full approval in combination with Lilly’s...
Read More...
-
![]()
How will the US market respond to Coherus’s two new biosimilars?
Biosimilars, or highly similar versions of high-price biologics, continue to grab market headlines with their...
Read More...
-
![]()
What half a century of innovation tells us about the tech industry
While many industries see huge change in half a century, few have been at the heart of so much constant…
Read More…
-
![]()
Move over GDPR: How a new ePrivacy regulation could affect businesses
The much-publicised General Data Protection Regulation (GDPR) has now been in force for nearly three months. The regulation gives individuals…
Read More…
-
![Brexit and the pharmaceutical industry]()
Brexit and the pharmaceutical industry: what happens if there’s no deal?
The pharmaceutical industry has voiced its increasing concerns about the possibility of no-deal Brexit when...
Read More...
-
![]()
A research headache: improving the understanding of chronic migraine
Like many neurological conditions, chronic migraine is poorly understood and ripe with unmet needs. Improving...
Read More...
-
![]()
Roche’s Rituxan biosimilar woes are just beginning
Last week, Roche filed a Worker Adjustment and Retraining Notification to the State of California’s...
Read More...
-
![]()
Competition heats up for oral antidiabetic drugs in T1D
Type 1 diabetes (T1D) patients may soon be taking oral antidiabetic drugs, namely sodium-glucose co-transporter...
Read More...
